Read More Pharma Industry News Bristol Myers Squibb signs $1.1bn multi-specific antibody discovery deal with Harbour BioMed Harbour BioMed signed a $1.125B discovery deal with Bristol Myers Squibb to co-develop multi-specific antibodies. Read the full strategic breakdown now. byPallavi MadhirajuDecember 17, 2025